Pre-mRNA splicing, a dynamic process of intron removal and exon joining, is governed by a combinatorial control exerted by overlapping cis-elements that are unique to each exon and its flanking intronic sequences. Splicing cis-elements are usually 4-to-8-nucleotide-long linear motifs that provide binding sites for specific proteins. Pre-mRNA splicing is also influenced by secondary and higher order RNA structures that affect accessibility of splicing cis-elements. Antisense oligonucleotides (ASOs) that block splicing cis-elements and/or affect RNA structure have been shown to modulate splicing in vivo. Therefore, ASO-based strategies have emerged as a powerful tool for therapeutic manipulation of splicing in pathological conditions. Here we describe an ASO-based approach to increase the production of the full-length SMN2 mRNA in spinal muscular atrophy patient cells.
CITATION STYLE
Singh, N. N., Luo, D., & Singh, R. N. (2018). Pre-mRNA Splicing Modulation by Antisense Oligonucleotides. In Methods in Molecular Biology (Vol. 1828, pp. 415–437). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8651-4_26
Mendeley helps you to discover research relevant for your work.